Related Experiment Videos
Malignant lymphoma presenting as initial symptom in the uterus
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Medical pregnancy termination in the presence of a massive uterine fibroid.
The British journal of clinical practice·1995
Maternal levels of serum-soluble CD8 and IL-2R are not significantly elevated in idiopathic preterm labour.
European journal of obstetrics, gynecology, and reproductive biology·1995
Cyclo-oxygenase distribution in human placenta and decidua does not change with labour after term or preterm delivery.
Gynecologic and obstetric investigation·1995
Placental heat shock proteins: no immunohistochemical evidence for a differential stress response in preterm labour.
Gynecologic and obstetric investigation·1995
Intra-uterine foetal death: an avoidable diagnostic pitfall.
Clinical and experimental obstetrics & gynecology·1991
The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration.
British journal of obstetrics and gynaecology·1999
Inconsistencies in classification by experts of cardiotocograms and subsequent clinical decision.
British journal of obstetrics and gynaecology·1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
British journal of obstetrics and gynaecology·1999
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
British journal of obstetrics and gynaecology·1999
Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated?
British journal of obstetrics and gynaecology·1999
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
British journal of obstetrics and gynaecology·1999
Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.
Frontiers in immunology·2026
Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.
Frontiers in immunology·2026